BIOMAT Database Logo BIOMAT Database Logo

Synthetic peptide thrombin inhibitor. 1994

A DeAnda, and S Coutré, and D C Miller

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D001896 Boron Compounds Inorganic or organic compounds that contain boron as an integral part of the molecule. Borides,Compounds, Boron
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

A DeAnda, and S Coutré, and D C Miller
Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
September 1996, Thrombosis and haemostasis,
A DeAnda, and S Coutré, and D C Miller
Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
October 1979, Thrombosis and haemostasis,
A DeAnda, and S Coutré, and D C Miller
In vivo characterization of a new synthetic thrombin inhibitor.
January 1992, Thrombosis and haemostasis,
A DeAnda, and S Coutré, and D C Miller
In vivo studies of a synthetic inhibitor of thrombin.
January 1982, The Journal of laboratory and clinical medicine,
A DeAnda, and S Coutré, and D C Miller
In vitro studies of a new synthetic thrombin inhibitor.
January 1985, Thrombosis research,
A DeAnda, and S Coutré, and D C Miller
Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis.
December 1996, Journal of cellular physiology,
A DeAnda, and S Coutré, and D C Miller
Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
January 1992, Seminars in thrombosis and hemostasis,
A DeAnda, and S Coutré, and D C Miller
Pharmacological characterization of a new highly effective synthetic thrombin inhibitor.
January 1985, Biomedica biochimica acta,
A DeAnda, and S Coutré, and D C Miller
Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
June 1996, Coronary artery disease,
A DeAnda, and S Coutré, and D C Miller
Thrombin-induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor.
December 1985, Thrombosis research,
Copied contents to your clipboard!